Class II · Moderate risk
Carton Label: MAJOR
Subpotent Drug
Is Methylergonovine recalled?
Yes — there is an active recall. 1 ongoing FDA recall mention Methylergonovine (4 total). Check the affected lots below.
Most common reason: Dissolution failure (1 of these recalls)
Recalls are matched by product description. A recall usually affects specific lots, not every package of Methylergonovine. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.
Methylergonovine recalls in 2026
1 initiated in 2026, 4 in total — newest first
Class II · Moderate risk
Methylergonovine Maleate Tablets
Failed Dissolution Specifications
Class III · Low risk
Methylergonovine Maleate USP 0.2 mg Tablets a) 12 count
Presence of Foreign Tablet/Capsule; one Promethazine tablet was found in a bottle of Methylergonovine Maleate tablets
Class II · Moderate risk
METHYLERGONOVINE MALEATE Tablet
Labeling: Label Mixup; METHYLERGONOVINE MALEATE Tablet, 0.2 mg may be potentially mislabeled as ISOSORBIDE MONONITRATE, Tablet, 20 mg, NDC 62175010701, Pedigree: AD52778_31, EXP: 5/20/2014; LEVOTHYROXINE SODIUM, Tablet, 88 mcg, NDC 00378180701, Pedigree: W003476, EXP: 6/20/2014.
Free recall alerts
Know the day your medication is recalled
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.